Lawsuit alleges Exactech concealed implant defects after TPG's 2018 acquisition, delaying recalls and risking patient safety, ...
GAINESVILLE, Fla., Feb. 18, 2025 /PRNewswire/ — Exactech, a global leader in medical technology, presented 15 new studies describing new research and advancements in total joint arthroplasty and ...
Exactech Launches Gibralt® OCT Spinal System for Complex Cervical Thoracic Spine Procedures Now Offe
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (NAS: EXAC) , which designs and manufactures bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, said that ...
The FDA reminded healthcare providers and patients on Thursday that several Exactech joint replacement devices packaged in defective bags should be closely monitored for device wear or failure. Many ...
Keep your eye on margins. Margins matter. The more Exactech (Nasdaq: EXAC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) ...
The US Patent and Trademark Office (USPTO) has issued patent 12,239,384 for Exactech’s Newton soft tissue balancing technology. This patent is part of a series of applications aimed at advancing the ...
All cash flow is not created equal. Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because ...
Medical devicemaker Exactech agreed to pay $8 million to settle allegations that it knowingly marketed and sold defective components within its line of Optetrak total knee systems, which have been ...
Medical device manufacturer Exactech has agreed to pay $8 million to settle allegations that it concealed defects in a popular line of artificial knee implants, which have been blamed for thousands of ...
Exactech Inc. (Nasdaq: EXAC) has agreed to acquire Altiva Corp., a Charlotte, N.C.-based maker of spinal implant devices and related products. The deal represents Exactech's decision to exercise a ...
It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" In this series, we measure how swiftly a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results